These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Escitalopram and enhancement of cognitive recovery following stroke. Jorge RE; Acion L; Moser D; Adams HP; Robinson RG Arch Gen Psychiatry; 2010 Feb; 67(2):187-96. PubMed ID: 20124118 [TBL] [Abstract][Full Text] [Related]
7. Prevention of depression with escitalopram in patients undergoing treatment for head and neck cancer: randomized, double-blind, placebo-controlled clinical trial. Lydiatt WM; Bessette D; Schmid KK; Sayles H; Burke WJ JAMA Otolaryngol Head Neck Surg; 2013 Jul; 139(7):678-86. PubMed ID: 23788218 [TBL] [Abstract][Full Text] [Related]
8. Prevention of poststroke apathy using escitalopram or problem-solving therapy. Mikami K; Jorge RE; Moser DJ; Arndt S; Jang M; Solodkin A; Small SL; Fonzetti P; Hegel MT; Robinson RG Am J Geriatr Psychiatry; 2013 Sep; 21(9):855-62. PubMed ID: 23930743 [TBL] [Abstract][Full Text] [Related]
9. Incomplete financial disclosure in a study of escitalopram and problem-solving therapy for prevention of poststroke depression. Robinson RG; Arndt S JAMA; 2009 Mar; 301(10):1023-4. PubMed ID: 19278945 [No Abstract] [Full Text] [Related]
10. Effect of Escitalopram on All-Cause Mortality and Hospitalization in Patients With Heart Failure and Depression: The MOOD-HF Randomized Clinical Trial. Angermann CE; Gelbrich G; Störk S; Gunold H; Edelmann F; Wachter R; Schunkert H; Graf T; Kindermann I; Haass M; Blankenberg S; Pankuweit S; Prettin C; Gottwik M; Böhm M; Faller H; Deckert J; Ertl G; JAMA; 2016 Jun; 315(24):2683-93. PubMed ID: 27367876 [TBL] [Abstract][Full Text] [Related]
11. Escitalopram maintenance treatment for prevention of recurrent depression: a randomized, placebo-controlled trial. Kornstein SG; Bose A; Li D; Saikali KG; Gandhi C J Clin Psychiatry; 2006 Nov; 67(11):1767-75. PubMed ID: 17196058 [TBL] [Abstract][Full Text] [Related]
12. Efficacy of early administration of escitalopram on depressive and emotional symptoms and neurological dysfunction after stroke: a multicentre, double-blind, randomised, placebo-controlled study. Kim JS; Lee EJ; Chang DI; Park JH; Ahn SH; Cha JK; Heo JH; Sohn SI; Lee BC; Kim DE; Kim HY; Kim S; Kwon DY; Kim J; Seo WK; Lee J; Park SW; Koh SH; Kim JY; Choi-Kwon S; Lancet Psychiatry; 2017 Jan; 4(1):33-41. PubMed ID: 28012485 [TBL] [Abstract][Full Text] [Related]
13. Depressive Symptoms in Stroke Patients: Are There Sex Differences? Lee EJ; Kim JS; Chang DI; Park JH; Ahn SH; Cha JK; Heo JH; Sohn SI; Lee BC; Kim DE; Kim HY; Kim S; Kwon DY; Kim J; Seo WK; Lee J; Park SW; Koh SH; Kim JY; Choi-Kwon S Cerebrovasc Dis; 2020; 49(1):19-25. PubMed ID: 32023608 [TBL] [Abstract][Full Text] [Related]
14. Duloxetine versus escitalopram and placebo in the treatment of patients with major depressive disorder: onset of antidepressant action, a non-inferiority study. Nierenberg AA; Greist JH; Mallinckrodt CH; Prakash A; Sambunaris A; Tollefson GD; Wohlreich MM Curr Med Res Opin; 2007 Feb; 23(2):401-16. PubMed ID: 17288694 [TBL] [Abstract][Full Text] [Related]
15. Prevention of Poststroke Mortality Using Problem-Solving Therapy or Escitalopram. Robinson RG; Jorge RE; Long J Am J Geriatr Psychiatry; 2017 May; 25(5):512-519. PubMed ID: 28029510 [TBL] [Abstract][Full Text] [Related]
16. Eszopiclone coadministered with escitalopram in patients with insomnia and comorbid generalized anxiety disorder. Pollack M; Kinrys G; Krystal A; McCall WV; Roth T; Schaefer K; Rubens R; Roach J; Huang H; Krishnan R Arch Gen Psychiatry; 2008 May; 65(5):551-62. PubMed ID: 18458207 [TBL] [Abstract][Full Text] [Related]
17. Increased frequency of first-episode poststroke depression after discontinuation of escitalopram. Mikami K; Jorge RE; Moser DJ; Arndt S; Jang M; Solodkin A; Small SL; Fonzetti P; Hegel MT; Robinson RG Stroke; 2011 Nov; 42(11):3281-3. PubMed ID: 21868736 [TBL] [Abstract][Full Text] [Related]
18. Escitalopram treatment for depressive disorder following acute coronary syndrome: a 24-week double-blind, placebo-controlled trial. Kim JM; Bae KY; Stewart R; Jung BO; Kang HJ; Kim SW; Shin IS; Hong YJ; Kim JH; Shin HY; Kang G; Ahn Y; Kim JK; Jeong MH; Yoon JS J Clin Psychiatry; 2015 Jan; 76(1):62-8. PubMed ID: 25375836 [TBL] [Abstract][Full Text] [Related]
19. Effect of escitalopram on mental stress-induced myocardial ischemia: results of the REMIT trial. Jiang W; Velazquez EJ; Kuchibhatla M; Samad Z; Boyle SH; Kuhn C; Becker RC; Ortel TL; Williams RB; Rogers JG; O'Connor C JAMA; 2013 May; 309(20):2139-49. PubMed ID: 23695483 [TBL] [Abstract][Full Text] [Related]
20. Fixed-dose trial of the single isomer SSRI escitalopram in depressed outpatients. Burke WJ; Gergel I; Bose A J Clin Psychiatry; 2002 Apr; 63(4):331-6. PubMed ID: 12000207 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]